GenAI can cut drug development costs by up to Rs 8 lakh cror

Report says it also has the potential to significantly shorten timelines, from identifying new drug targets to getting medications ready for clinical trials

Related Keywords

India , Hyderabad , Andhra Pradesh , Telangana , United States , Shakthi Nagappan , Suresh Subramanian , Partner National Life Sciences Leader , Promotion Of Research , Pfizer , Life Sciences , Generative Artificial Intelligence , National Life Sciences Leader , Pharma Medtech Sector , Artificial Intelligence , Genai , Drug Development , Clinical Trials , Generic Medicines , Ow Cost Vaccines , Hi ,